搜索





搜索





Entrada Therapeutics Inc

TRDA

添加自选

6.220USD

-0.280-4.31%

收盘 09-24 16:00（美东）

241.46M总市值

亏损市盈率 TTM

Entrada Therapeutics Inc

6.220

-0.280-4.31%

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

概览

新闻分析

财务

股票评分

技术分析

预测

持股情况

股息

公司资料

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

TRDA 现金流量表

您可以访问Entrada Therapeutics Inc的年度和季度现金流量表，以评估其财务稳健性和稳定性。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2020Q4

FY2020Q3

经营活动现金流量（间接法）

持续经营活动现金净额

-10.09%-32.46M

-8.28%-41.70M

-1.89%-32.20M

-16.68%-28.31M

-174.03%-29.49M

-50.90%-38.51M

-687.57%-31.61M

0.92%-24.27M

213.51%39.83M

-112.55%-25.52M

85.30%-4.01M

10.88%-24.49M

-94.85%-35.09M

1068.98%203.40M

-32.92%-27.30M

-95.25%-27.48M

---18.01M

---20.99M

-210.10%-20.54M

-149.34%-14.07M

---6.62M

---5.64M

持续经营净收入

0.79%-42.76M

-128.93%-39.72M

-3562.78%-39.16M

-214.52%-44.13M

-178.32%-43.10M

-173.84%-17.35M

111.85%1.13M

-139.57%-14.03M

312.25%55.03M

452.05%23.50M

61.25%-9.54M

241.07%35.46M

-11.86%-25.93M

69.20%-6.67M

-33.51%-24.63M

-74.20%-25.14M

---23.18M

---21.67M

-112.69%-18.45M

-106.44%-14.43M

---8.67M

---6.99M

持续经营损益

-18.67%841.00K

-14.90%805.00K

-10.69%886.00K

31.27%1.23M

13.63%1.03M

1.28%946.00K

34.78%992.00K

12.35%937.00K

24.66%910.00K

72.64%934.00K

40.19%736.00K

62.26%834.00K

56.65%730.00K

38.72%541.00K

44.23%525.00K

70.20%514.00K

--466.00K

--390.00K

271.43%364.00K

235.56%302.00K

--98.00K

--90.00K

其他非现金项目

53.17%-450.00K

59.04%-548.00K

74.75%-633.00K

77.00%-739.00K

57.50%-961.00K

34.32%-1.34M

-25.41%-2.51M

-73.49%-3.21M

-33.71%-2.26M

-759.49%-2.04M

-1822.12%-2.00M

-5687.50%-1.85M

-1290.85%-1.69M

-266.90%-237.00K

---104.00K

---32.00K

--142.00K

----

营运资金变化

-43.97%4.76M

73.01%-6.98M

106.54%2.35M

179.68%10.21M

145.99%8.49M

49.94%-25.85M

-1316.42%-35.92M

79.44%-12.82M

-63.14%-18.47M

-124.95%-51.65M

149.39%2.95M

-1025.92%-62.33M

-652.24%-11.32M

12676.79%207.01M

-55.82%-5.98M

-716.52%-5.54M

--2.05M

---1.65M

-308.53%-3.84M

-157.46%-678.00K

--1.84M

--1.18M

-应收款项（增）减

-103.36%-29.00K

-76.16%390.00K

101.76%19.00K

-100.32%-16.00K

-98.76%864.00K

102.28%1.64M

-26.26%-1.08M

495.86%5.07M

2635.61%69.84M

-1037.62%-71.64M

---853.00K

---1.28M

--2.55M

---6.30M

----

-预付费用（增）减

-50.92%2.30M

-8.27%-2.46M

150.59%1.50M

393.32%3.73M

262.95%4.68M

-184.81%-2.27M

-123.75%-2.97M

91.39%-1.27M

-143.88%-2.87M

-38.23%2.68M

725.17%12.52M

-55.36%-14.78M

881.03%6.54M

359.82%4.34M

68.14%-2.00M

-1332.53%-9.51M

---838.00K

---1.67M

-494.97%-6.28M

-224.34%-664.00K

--1.59M

--534.00K

-其他流动资产变化

-39.29%1.69M

-38.99%1.67M

-43.37%1.76M

37.53%3.60M

-39.35%2.78M

7.11%2.74M

201.26%3.12M

43.47%2.61M

59.77%4.59M

148.29%2.56M

146.70%1.03M

-6.23%1.82M

11.97%2.87M

-619.71%-5.30M

-239.07%-2.21M

200.31%1.94M

--2.56M

--1.02M

52966.67%1.59M

-2880.00%-1.94M

--3.00K

---65.00K

-其他流动负债变化

89.48%-81.00K

99.52%-88.00K

99.64%-122.00K

97.53%-419.00K

99.12%-770.00K

-203.46%-18.51M

-77.73%-33.72M

55.60%-16.97M

-503.22%-87.02M

-91.54%17.89M

---18.97M

---38.21M

---14.43M

--211.58M

-100.00%0.00

----

--0.00

272.73%57.00K

-1485.71%-222.00K

---33.00K

---14.00K

非持续经营活动现金净额

经营活动现金净额

-10.09%-32.46M

-8.28%-41.70M

-1.89%-32.20M

-16.68%-28.31M

-174.03%-29.49M

-50.90%-38.51M

-687.57%-31.61M

0.92%-24.27M

213.51%39.83M

-112.55%-25.52M

85.30%-4.01M

10.88%-24.49M

-94.85%-35.09M

1068.98%203.40M

-32.92%-27.30M

-95.25%-27.48M

---18.01M

---20.99M

-210.10%-20.54M

-149.34%-14.07M

---6.62M

---5.64M

投资活动现金流量

持续投资活动现金净额

-96.00%11.00K

-96.15%44.00K

-132.60%-207.00K

-126.76%-171.00K

-73.71%275.00K

36.52%1.14M

-34.94%635.00K

-55.87%639.00K

-31.27%1.05M

-49.76%838.00K

37.85%976.00K

78.77%1.45M

96.39%1.52M

180.81%1.67M

-46.44%708.00K

0.50%810.00K

--775.00K

--594.00K

-8.89%1.32M

240.08%806.00K

--1.45M

--237.00K

资本性支出

-96.00%11.00K

-96.15%44.00K

----

-73.71%275.00K

36.52%1.14M

-34.94%635.00K

-55.87%639.00K

-31.27%1.05M

-49.76%838.00K

37.85%976.00K

78.77%1.45M

96.39%1.52M

180.81%1.67M

-46.44%708.00K

0.50%810.00K

--775.00K

--594.00K

-8.89%1.32M

240.08%806.00K

--1.45M

--237.00K

固定资产交易的净现金流

-96.00%11.00K

-96.15%44.00K

-132.60%-207.00K

-126.76%-171.00K

-73.71%275.00K

36.52%1.14M

-34.94%635.00K

-55.87%639.00K

-31.27%1.05M

-49.76%838.00K

37.85%976.00K

78.77%1.45M

96.39%1.52M

180.81%1.67M

-46.44%708.00K

0.50%810.00K

--775.00K

--594.00K

-8.89%1.32M

240.08%806.00K

--1.45M

--237.00K

投资产品交易的净现金流

61.31%54.96M

356.07%27.03M

-46.46%28.91M

159.47%48.94M

246.00%34.07M

-78.04%5.93M

169.74%54.00M

-3494.93%-82.29M

79.11%-23.34M

169.59%26.98M

2.66%20.02M

75.45%-2.29M

-546.94%-111.73M

78.57%-38.78M

--19.50M

---9.32M

--25.00M

---180.94M

----

其他投资活动的净现金流

--0.00

----

非持续投资活动现金净额

投资活动现金净额

62.59%54.95M

464.23%26.99M

-45.43%29.12M

159.22%49.11M

238.61%33.80M

-81.71%4.78M

180.23%53.37M

-2119.08%-82.93M

78.47%-24.38M

164.65%26.15M

1.34%19.04M

63.12%-3.74M

-567.52%-113.26M

77.72%-40.44M

1521.48%18.79M

-1157.32%-10.13M

--24.23M

---181.53M

8.89%-1.32M

-240.08%-806.00K

---1.45M

---237.00K

融资活动现金流量

持续融资活动现金净额

3.86%350.00K

-71.43%100.00K

-86.31%192.00K

172.73%8.00K

-99.67%337.00K

69.90%350.00K

103.19%1.40M

-102.99%-11.00K

22781.94%101.37M

-98.95%206.00K

92.74%690.00K

513.33%368.00K

3927.27%443.00K

38972.00%19.54M

-99.81%358.00K

-43.40%60.00K

--11.00K

--50.00K

127923.49%190.75M

-99.57%106.00K

--149.00K

--24.86M

普通股发行/偿还的净现金流

0.95%320.00K

----

-53.38%145.00K

100.00%0.00

-99.68%317.00K

----

-54.93%311.00K

-206.52%-392.00K

22532.73%100.26M

-100.00%0.00

142.96%690.00K

--368.00K

--443.00K

--19.54M

-99.85%284.00K

----

--190.69M

----

优先股发行/偿还的净现金流

----

--0.00

-100.00%0.00

--0.00

--24.86M

职工行使股票期权收到的现金

50.00%30.00K

-71.43%100.00K

-95.69%47.00K

-97.90%8.00K

-98.19%20.00K

69.90%350.00K

--1.09M

--381.00K

--1.10M

--206.00K

----

15.63%74.00K

-43.40%60.00K

--11.00K

--50.00K

-57.05%64.00K

--106.00K

--149.00K

--0.00

其他融资活动的净现金流额

--320.00K

--0.00

----

非持续融资活动现金净额

融资活动现金净额

3.86%350.00K

-71.43%100.00K

-86.31%192.00K

172.73%8.00K

-99.67%337.00K

69.90%350.00K

103.19%1.40M

-102.99%-11.00K

22781.94%101.37M

-98.95%206.00K

92.74%690.00K

513.33%368.00K

3927.27%443.00K

38972.00%19.54M

-99.81%358.00K

-43.40%60.00K

--11.00K

--50.00K

127923.49%190.75M

-99.57%106.00K

--149.00K

--24.86M

现金净流量

期初现金流

11.07%79.74M

-10.29%94.34M

18.58%97.24M

-59.60%76.43M

-0.83%71.79M

46.97%105.16M

46.87%82.00M

126.07%189.20M

-68.74%72.39M

45.71%71.55M

-2.50%55.83M

-11.73%83.69M

161.43%231.60M

-83.13%49.11M

-53.13%57.26M

-30.76%94.82M

--88.59M

--291.06M

160.10%122.17M

389.29%136.95M

--46.97M

--27.99M

当期现金流变化

391.63%22.84M

56.23%-14.61M

-112.49%-2.89M

119.41%20.80M

-96.02%4.64M

-4101.68%-33.37M

47.34%23.16M

-284.78%-107.20M

178.98%116.82M

-99.54%834.00K

292.79%15.72M

25.81%-27.86M

-2475.22%-147.91M

190.13%182.49M

-104.83%-8.15M

-154.19%-37.56M

--6.23M

---202.47M

2230.86%168.89M

-177.84%-14.78M

---7.93M

--18.98M

期末现金流

34.20%102.57M

11.07%79.74M

-10.29%94.34M

18.58%97.24M

-59.60%76.43M

-0.83%71.79M

46.97%105.16M

46.87%82.00M

126.07%189.20M

-68.74%72.39M

45.71%71.55M

-2.50%55.83M

-11.73%83.69M

161.43%231.60M

-83.13%49.11M

-53.13%57.26M

--94.82M

--88.59M

645.46%291.06M

160.10%122.17M

--39.05M

--46.97M

自由现金流

-9.10%-32.47M

-5.27%-41.74M

0.11%-32.20M

-13.68%-28.31M

-176.74%-29.76M

-50.44%-39.65M

-546.22%-32.24M

3.99%-24.91M

205.94%38.79M

-113.07%-26.36M

82.19%-4.99M

8.31%-25.94M

-94.92%-36.61M

1034.59%201.73M

-28.13%-28.01M

-90.12%-28.29M

---18.78M

---21.59M

-170.75%-21.86M

-152.99%-14.88M

---8.07M

---5.88M

货币单位

--USD

审计意见

----

常见问题

什么是经营活动现金流？



经营活动现金流是公司核心业务产生或使用的现金。它以净利润为基础，并对折旧等非现金项目以及应收账款、存货和应付账款等营运资金变动进行调整。强劲的经营活动现金流通常表明，公司能够将销售收入和利润有效转化为实际现金。

Entrada Therapeutics Inc 产生了多少经营活动现金流？



Entrada Therapeutics Inc 2025 财年的经营活动现金流为 -128.51M，反映其核心业务经营活动产生的现金。

Entrada Therapeutics Inc 的经营活动现金流同比有何变化？



Entrada Therapeutics Inc 的经营活动现金流同比增长 -209.24%。

什么是投资活动现金流？



投资活动现金流反映公司投资相关活动所使用或产生的现金，例如资本支出、投资买卖、企业收购和资产处置。投资活动现金流为负并不一定是坏事，因为这可能意味着公司正在为未来增长进行投入。不过，投资者仍需判断这些投资能否带来长期回报。

Entrada Therapeutics Inc 的资本支出是多少？



Entrada Therapeutics Inc 最近一个季度的资本支出为 1.04M。

什么是融资活动现金流？



融资活动现金流反映公司如何筹集资金，或向投资者和债权人返还资金，包括发行和偿还债务、发行和回购股份、支付股息以及租赁融资等。融资活动现金流为正，可能表示公司筹集了新资金；为负则可能反映公司正在偿还债务、派发股息或回购股份。

Entrada Therapeutics Inc 的融资活动现金流有何变化？



Entrada Therapeutics Inc 最近一个季度用于融资活动的现金为 887.00K。

什么是自由现金流？它对 TRDA 有何重要意义？



自由现金流是公司在支付维持或拓展业务所需的资本支出后剩余的现金。它通常用于评估公司的财务灵活性、偿债能力、股息可持续性、股份回购能力和估值水平。投资者还应将自由现金流与净利润、营收增长和资本支出结合分析。

Entrada Therapeutics Inc 最近一个季度的自由现金流是多少？



Entrada Therapeutics Inc 最近一个季度的自由现金流为 -129.55M，较上年同期变动 -189.73%。